Literature DB >> 27623321

Exercise training in COPD: What is it about intensity?

Norman R Morris1,2, James Walsh3,4, Lewis Adams3, Jennifer Alision5,6.   

Abstract

Most of the current guidelines for pulmonary rehabilitation recommend higher, over lower, intensity exercise training for COPD. Typically, we consider intensity of exercise training to be a key component of any exercise training programme. Whilst studies of young individuals have demonstrated that higher exercise training intensity results in greater improvements in exercise capacity, the evidence for older patients is not so clear cut. In COPD, there is limited evidence regarding the optimal intensity of exercise training. Using both physiological (peak exercise capacity) and patient-centred (e.g. quality of life) outcomes, it remains inconclusive if higher intensity exercise training bestows any greater benefit than low-intensity exercise. If we examine the data from interval training studies, which used both high- and low-intensity interval and continuous exercise, we are able to generate more data for comparison. Unfortunately, these data are challenging to interpret due to heterogeneity in how interval training was prescribed. However, when we normalize the interval training data for training volume and examine the change in peak cycling power, there is a relationship between training intensity and increase in peak power (Wpeak , r = 0.68, P < 0.05). Hence, whilst there is an inconclusive amount of evidence to support this intervention based on studies that only examined high- versus low-intensity continuous exercise, the additional data from interval training studies would suggest that higher intensity may be superior in terms of increases in Wpeak . Future studies should focus on establishing a threshold and an optimal training intensity for COPD.
© 2016 Asian Pacific Society of Respirology.

Entities:  

Keywords:  chronic obstructive pulmonary disease; exercise and pulmonary rehabilitation

Mesh:

Year:  2016        PMID: 27623321     DOI: 10.1111/resp.12864

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  6 in total

1.  Physical activity and sedentary time are related to clinically relevant health outcomes among adults with obstructive lung disease.

Authors:  Shilpa Dogra; Joshua Good; Matthew P Buman; Paul A Gardiner; Jennifer L Copeland; Michael K Stickland
Journal:  BMC Pulm Med       Date:  2018-06-07       Impact factor: 3.317

2.  Benefits of different intensities of pulmonary rehabilitation for patients with moderate-to-severe COPD according to the GOLD stage: a prospective, multicenter, single-blinded, randomized, controlled trial.

Authors:  Guo Xia He; Ning Li; Lei Ren; Hong Hua Shen; Ning Liao; Jian Jun Wen; Yi Min Xu; Jing Wang; Qing Yun Li
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-10-08

Review 3.  Effects of high intensity interval training on exercise capacity in people with chronic pulmonary conditions: a narrative review.

Authors:  Abbey Sawyer; Vinicius Cavalheri; Kylie Hill
Journal:  BMC Sports Sci Med Rehabil       Date:  2020-03-30

Review 4.  Towards Personalized Management of Sarcopenia in COPD.

Authors:  Sophie I J van Bakel; Harry R Gosker; Ramon C Langen; Annemie M W J Schols
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-01-07

5.  High intensity interval training versus moderate intensity continuous training for people with interstitial lung disease: protocol for a randomised controlled trial.

Authors:  Leona M Dowman; Anthony K May; Catherine J Hill; Janet Bondarenko; Lissa Spencer; Norman R Morris; Jennifer A Alison; James Walsh; Nicole S L Goh; Tamera Corte; Ian Glaspole; Daniel C Chambers; Christine F McDonald; Anne E Holland
Journal:  BMC Pulm Med       Date:  2021-11-10       Impact factor: 3.317

6.  A pilot randomized aerobic exercise trial in older HIV-infected men: Insights into strategies for successful aging with HIV.

Authors:  Krisann K Oursler; John D Sorkin; Alice S Ryan; Leslie I Katzel
Journal:  PLoS One       Date:  2018-06-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.